Investor mix
15 investors on record; lead investors include Gimv, Lundbeck Foundation, INNOBIO, APICAP; 7 have since exited.
| Investor type | Count | Share |
|---|---|---|
| Private equity | 8 | 53% |
| Bank & private debt | 3 | 20% |
| Other / undisclosed | 4 | 27% |
Developer of hemostatic products for surgical applications
15 investors on record; lead investors include Gimv, Lundbeck Foundation, INNOBIO, APICAP; 7 have since exited.
| Investor type | Count | Share |
|---|---|---|
| Private equity | 8 | 53% |
| Bank & private debt | 3 | 20% |
| Other / undisclosed | 4 | 27% |